1 / 7

Respiratory Drugs And Devices Market Size, share, Industry Growth, Future Prospects, Opportunities, Forecast 2018-2023

Respiratory Drugs And Devices Market Size, share, Industry Growth, Future Prospects, Opportunities, Forecast 2018-2023

preeti18
Télécharger la présentation

Respiratory Drugs And Devices Market Size, share, Industry Growth, Future Prospects, Opportunities, Forecast 2018-2023

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Orion Market Research Respiratory Drugs And Devices Market Size, Competitive Analysis, Share, Forecast- 2018-2023 Request a Free Sample @ https://www.omrglobal.com/request-sample/respiratory-drugs- devices-market Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404

  2. Respiratory drugs and devices are used to treat respiratory diseases. Major respiratory diseases are asthma, COPD, Bronchitis, and cystic fibrosis. The respiratory drug and device market is anticipated to grow at a CAGR of 7% during the forecast period. As compared to respiratory medical devices, the market of drug is far larger which is driving the overall market. North America is leading the drug market globally. It is due to significant market of patented and branded generic drugs in the region. Around 67%-69% of total market is of respiratory drugs in 2018. Companies such as Astrazeneca, Chiesi Farmaceutici, Merck, Novartis, Roche, Teva, are significantly contributing to the drug market. These companies have more than 50% of the total drug market globally. To copy @ https://www.omrglobal.com/request-sample/respiratory-drugs-devices-market learn more about this report request a free sample Factors that are augmenting the market include predominance of chronic respiratory diseases such as asthma, COPD and so on, overgrowing geriatric population, changing lifestyle activities among people and innovations and development of new products. Asthma is one of the major non-communicable diseases globally affect almost each major economy. As per WHO, about 235 million people have asthma related diseases globally. It is most common communicable disease in children however maximum mortalities are observed in elderly population. It is highly prevalent in high-income countries however developing economies share a large part of mortalities. Browse reports/respiratory-drugs-devices-market for Full Report Description@ https://www.omrglobal.com/industry- Another major factor that is expanding respiratory drug and device market size is overgrowing geriatric population in the major economies of the globe. People of this age group are more prone to respiratory diseases such as Asthma and COPD. As per World Bank, in 2010, geriatric population were 7.6% in 2010 which was equal to 524 million and it has been increased to 8.4% in 2016. It is forecast that it will reach 1.5 billion in 2050 with a share of 16% of total population. More notable point is that, developed and technological advance economies have higher percentage of geriatric population as compare to developing economies & global average. Moreover, as per Centre for Diseases Control and Prevention, about 11.5 million asthma attacks were observed in 2015 including 3 million in children in the US. As per Asthma UK, about 5.4 million people are suffering from asthma in the UK in 2016. Out of 5.4 million people, asthma is prevalent in 4.3 million adults and 1.1 million in children. As per WHO, India is estimated to have about 15-20 million asthma patients in 2017. It is also on high rise in China, as per Asia Asthma Development Board, there were about 36.7 patients of asthma per 100,000 people. There are more than 30 million people living with Asthma in the China. These facts and figures address the demand for respiratory drugs and devices; thereby, expanding the global market size.

  3. Global Respiratory Drugs and Devices Market Segmentation By Type Drugs Devices Global Respiratory Drugs and Devices Market – Segment by Region North America US Canada Europe Germany UK France Spain Italy Rest of Europe Asia-Pacific China Japan India Rest of Asia-Pacific Rest of the World Latin America Middle East and Africa COMPANY PROFILES ASTRAZENECA ADAMIS (ADMP) ADS BIOTECHNOLOGY AIR LIQUIDE ALIOS BIOPHARMA INC.

  4. ALUNG TECHNOLOGIES ALVOGEN ANAXSYS APPLIED BIOCODE INC APTIMMUNE BIOLOGICS INC APTUIT ARADIGM AROS PHARMA APS ARROW THERAPEUTICS, LTD. AVITA MEDICAL BAXTER INTERNATIONAL BAYER AG BEXIMCO PHARMACEUTICALS LTD BIOMARCK PHARMACEUTICALS, LTD BIOXYDYN LIMITED BOEHRINGER INGELHEIM CAPELLON PHARMACEUTICALS, LTD. CHART INDUSTRIES CHIESI FARMACEUTICI S.P.A CIRCADIANCE CIRCASSIA. CIVITAS THERAPEUTICS, INC. COMPUMEDICS LIMITED COVIDIEN PLC DAINIPPON SUMITOMO PHARMA CO., LTD. DRAGER MEDICAL GMBH EDIMER PHARMACEUTICALS EDIXOMED LTD. ENANTA PHARMACEUTICALS FARON

  5. FISHER AND PAYKEL HEALTHCARE CORP. LTD GE HEALTHCARE LIMITED GECKO HEALTH INNOVATIONS, INC. GILBERT TECHNOLOGIES GILEAD SCIENCES, INC. GLAXOSMITHKLINE GRIFOLS H&T PRESSPART HAMILTON MEDICAL AG INVACARE CORPORATION MERCK AND CO. MERIDIAN BIOSCIENCE METHAPHARM MICROBOT MEDICAL MYLAN NABRIVA THERAPEUTICS NEPHRON PHARMACEUTICALS CORPORATION NOVABIOTICS NOVALUNG NOVARTIS AG NOX MEDICAL ONCOLYTICS BIOTECH OPKO HEALTH OREXO ORION CORPORATION OTSUKA PHARMACEUTICALS OXAGEN LIMITED OXEHEALTH PALOBIOFARMA SL PATARA PHARMA

  6. PATHWAY THERAPEUTICS LTD PEPTINNOVATE PFIZER PHARMAXIS PHARMAXIS PHILIPS HEALTHCARE PIERIS PHARMACEUTICALS PLAIR SA PMD SOLUTIONS PNEUMACARE LIMITED PROPELLER HEALTH PULMOTECT, INC. REPLICOR RESPEQ RESPICARDIA RESPIRATORY MOTION ROCHE DIAGNOSTICS SAVARA INC. SIME DIAGNOSTICS LTD SUNOVION PHARMACEUTICALS INC SYNAIRGEN SYNAPSE BIOMEDICAL TAKEDA PHARMACEUTICAL COMPANY LIMITED, TECHNO DRUGS LTD. TEICOS PHARMA OY TEIJIN PHARMA LTD. TEVA PHARMACEUTICALS TOTALCARE EHEALTH VALEANT PHARMACEUTICALS VAPOTHERM

  7. VENTIRX PHARMACEUTICALS, INC. VERONA PHARMA PLC VERTEX PHARMACEUTICALS VIDA THERAPEUTICS INC. VIRIONHEALTH LIMITED VIROBLOCK SA VIROCLINICS BIOSCIENCES B.V. WINDTREE THERAPEUTICS For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/respiratory-drugs-devices-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404

More Related